← ANALYST RATINGS · TIPRANKS

Lifestance Health Group (LFST): analyst forecast and price target

$11.74 −5.09% close 16.10.26 · market cap $4.7B · Healthcare · Medical - Care Facilities IWM 0.10%
Price targets and ratings of

Analyst consensus

Strong Buy

5 Buy1 Hold0 Sell

Ratings of 6 analysts in the last 3 months · top analysts only

12-month forecast

$14.20+21.0% upside

Based on 6 price targets given in the last 3 months, the average target is $14.20, the highest $15.00, the lowest $13.00. The average is +21.0% from the last price of $11.74.

$5.00$10.00$15.00Jan 26AprJulOctJan 27AprJulOctHigh$15.00Average$14.20Low$13.00
Highest target $15.00 Average target $14.20 Lowest target $13.00
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Richard Close★★★★★★★★★★#1081 · hits 49% · avg +10.0% Canaccord Genuity $15.00 Buy +27.8% Reiterated 14.10.26on TipRanks Oct 15 07:30 +2.7%next day −1.5%
Scott Schoenhaus★★★★★★★★★★#12104 · hits 35% · avg −9.7% KeyBanc $15.00 Buy +27.8% Reiterated 05.10.26on TipRanks 04:55 +2.6%next day −1.4% · 5 days +1.7%
Jack Slevin★★★★★★★★★★#2268 · hits 61% · avg +22.1% Jefferies $14.00 → $15.00+7.1% Buy +27.8% Reiterated 25.09.26on TipRanks 09:55 −0.2%next day +0.7% · 5 days +0.1%
Peter Warendorf★★★★★★★★★★#2259 · hits 83% · avg +21.9% Barclays $13.00 → $15.00+15.4% Buy +27.8% Reiterated 10.09.26on TipRanks 05:36 +3.6%next day −1.1% · 5 days −3.6%
Ryan Daniels★★★★★★★★★★#2878 · hits 48% · avg +5.8% William Blair — Buy — Reiterated 21.08.26on TipRanks 06:17 −1.8%next day −2.2% · 5 days −1.8%
David Larsen★★★★★★★★★★#12072 · hits 35% · avg −4.7% BTIG $16.00 → $18.00+12.5% Buy +53.3% Reiterated 19.08.26on TipRanks 07:30 +3.6%next day −0.6% · 5 days −4.9%
Lisa Gill★★★★★★★★★★#1237 · hits 58% · avg +9.0% J.P. Morgan $9.00 → $13.00+44.4% Hold +10.7% Reiterated 14.08.26on TipRanks 07:55 +1.8%next day +1.5% · 5 days +1.8%
Craig Hettenbach★★★★★★★★★★#1537 · hits 59% · avg +7.6% Morgan Stanley $13.00 Buy +10.7% Assigned 12.08.26on TipRanks 08:20 +6.1%next day −0.8% · 5 days +5.3%
Sean Dodge★★★★★★★★★★#11980 · hits 43% · avg −4.3% BMO Capital $11.00 → $13.00+18.2% Buy +10.7% Assigned 06.08.26on TipRanks Aug 7 07:55 +3.0%next day +1.1% · 5 days +13.4%
Steve Dechert★★★★★★★★★★#4194 · hits 86% · avg +25.9% KeyBanc $11.00 → $13.00+18.2% Buy +10.7% Reiterated 13.07.26on TipRanks 05:15 +2.4%next day −1.2% · 5 days +5.2%
Scott Fidel★★★★★★★★★★#1346 · hits 64% · avg +7.9% Goldman Sachs $9.00 Hold −23.3% Initiated 05.06.26on TipRanks Jun 6 11:20 −0.4%next day −1.2% · 5 days +14.1%
Kevin Caliendo★★★★★★★★★★#2646 · hits 56% · avg +5.6% UBS $12.00 → $13.00+8.3% Buy +10.7% Reiterated 08.05.26on TipRanks 11:00 −13.8%next day −0.6% · 5 days −0.9%

The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included

Best analysts covering Lifestance Health Group

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Peter Warendorf★★★★★★★★★★Barclays · #2259
Hits 83%19 of 23 Average return +21.9%
1 year David Larsen★★★★★★★★★★BTIG · #12072
Hits 35%162 of 466 Average return −4.7%
2 years David Larsen★★★★★★★★★★BTIG · #12072
Hits 35%162 of 466 Average return −4.7%

Most profitable

3 months Peter Warendorf★★★★★★★★★★Barclays · #2259
Hits 83%19 of 23 Average return +21.9%
1 year David Larsen★★★★★★★★★★BTIG · #12072
Hits 35%162 of 466 Average return −4.7%
2 years Richard Close★★★★★★★★★★Canaccord Genuity · #1081
Hits 49%237 of 482 Average return +10.0%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $14.38 at a price of $12.03 (+19.5%); now: $14.62 at $11.74 (+24.6%).

$12.00$13.00$14.00Sep 15Oct 1Oct 15Top analysts$14.20Average target$14.62Price$11.74

PriceAverage targetTop analysts’ target

Recommendation trend · top analysts

051042Oct 2533Nov23Dec25Jan 2617Feb17Mar17Apr182May183Jun193Jul102Aug121Sep101Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy111000
Buy889101210
Hold233211
Sell000000

Earnings and sales forecast

Next report: 05.11.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $0.04 (from $0.01 to $0.07). Last quarter: $0.06.

Sales

Next quarter’s sales estimate — $432M (from $426M to $437M). Last quarter: $435M.

Best top-analyst consensus in the sector · Healthcare

AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
About Lifestance Health Group
  • CEO: David Patrick Bourdon
  • Employees: 8,542
  • 4800 N. Scottsdale Road, Scottsdale, AZ, 85251, US
  • www.lifestance.com

LifeStance Health Group, Inc. specializes in delivering outpatient mental healthcare services through its subsidiary network. The company offers a comprehensive array of mental health solutions, encompassing psychiatric evaluations and treatment, specialized psychological and neuropsychological testing, and diverse therapeutic modalities including individual, family, and group therapy sessions. The organization addresses a wide spectrum of mental health conditions, ranging from common issues like anxiety and depression to more complex challenges such as bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. Patients have access to care through various channels: virtually via its online platform or in-person at its many centers located throughout 32 states. LifeStance is dedicated to supporting individuals across all age groups, providing care for children, adolescents, adults, and the elderly. LifeStance Health Group, Inc. was founded in 2017 and its main offices are situated in Scottsdale, Arizona.

Data from the stock’s TipRanks forecast page, read 7 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗